These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38031066)

  • 41. Non communicable disease multimorbidity and associated health care utilization and expenditures in India: cross-sectional study.
    Pati S; Agrawal S; Swain S; Lee JT; Vellakkal S; Hussain MA; Millett C
    BMC Health Serv Res; 2014 Oct; 14():451. PubMed ID: 25274447
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Findings from the Indonesian family life survey on patterns and factors associated with multimorbidity.
    Griselda M; Alfian SD; Wicaksono IA; Wawruch M; Abdulah R
    Sci Rep; 2023 Oct; 13(1):18607. PubMed ID: 37903815
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Stroke, multimorbidity and polypharmacy in a nationally representative sample of 1,424,378 patients in Scotland: implications for treatment burden.
    Gallacher KI; Batty GD; McLean G; Mercer SW; Guthrie B; May CR; Langhorne P; Mair FS
    BMC Med; 2014 Oct; 12():151. PubMed ID: 25280748
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevalence of and factors associated with multimorbidity among 18 101 adults in the South East Asia Community Observatory Health and Demographic Surveillance System in Malaysia: a population-based, cross-sectional study of the MUTUAL consortium.
    Tan MMC; Prina AM; Muniz-Terrera G; Mohan D; Ismail R; Assefa E; Keinert AÁM; Kassim Z; Allotey P; Reidpath D; Su TT
    BMJ Open; 2022 Dec; 12(12):e068172. PubMed ID: 36564121
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mobile App-Reported Use of Traditional Medicine for Maintenance of Health in India During the COVID-19 Pandemic: Cross-sectional Questionnaire Study.
    Srikanth N; Rana R; Singhal R; Jameela S; Singh R; Khanduri S; Tripathi A; Goel S; Chhatre L; Chandra A; Rao BCS; Dhiman KS
    JMIRx Med; 2021; 2(2):e25703. PubMed ID: 34032815
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevalence of multimorbidity and associated treatment burden in primary care settings in Kerala: a cross-sectional study in Malappuram District, Kerala, India.
    Ismail S; Stanley A; Jeemon P
    Wellcome Open Res; 2022; 7():67. PubMed ID: 35592547
    [No Abstract]   [Full Text] [Related]  

  • 47. Multimorbidity and social determinants of health in the US prior to the COVID-19 pandemic and implications for health outcomes: a cross-sectional analysis based on NHANES 2017-2018.
    Mossadeghi B; Caixeta R; Ondarsuhu D; Luciani S; Hambleton IR; Hennis AJM
    BMC Public Health; 2023 May; 23(1):887. PubMed ID: 37189096
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prediction of Multimorbidity in Brazil: Latest Fifth of a Century Population Study.
    Li XL; Huang H; Lu Y; Stafford RS; Lima SM; Mota C; Shi X
    JMIR Public Health Surveill; 2023 May; 9():e44647. PubMed ID: 37252771
    [TBL] [Abstract][Full Text] [Related]  

  • 49. "Getting the water-carrier to light the lamps": Discrepant role perceptions of traditional, complementary, and alternative medical practitioners in government health facilities in India.
    Josyula KL; Sheikh K; Nambiar D; Narayan VV; Sathyanarayana TN; Porter JDH
    Soc Sci Med; 2016 Oct; 166():214-222. PubMed ID: 27575933
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Exploring the relationship between depression and different multimorbidity patterns among older people covered by long-term care insurance in Shanghai, China.
    Li C; Peng W; Li M; Li X; Yang T; Yan H; Wang Z; Jia X; Hu Z; Wang Y
    Psychogeriatrics; 2022 Jan; 22(1):99-107. PubMed ID: 34743400
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multimorbidity and use of hypnotic and anxiolytic drugs: cross-sectional and follow-up study in primary healthcare in Iceland.
    Linnet K; Gudmundsson LS; Birgisdottir FG; Sigurdsson EL; Johannsson M; Tomasdottir MO; Sigurdsson JA
    BMC Fam Pract; 2016 Jun; 17():69. PubMed ID: 27267943
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Family-Level Multimorbidity among Older Adults in India: Looking through a Syndemic Lens.
    Pati S; Sinha A; Ghosal S; Kerketta S; Lee JT; Kanungo S
    Int J Environ Res Public Health; 2022 Aug; 19(16):. PubMed ID: 36011486
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevalence of anxiety and depressive symptoms and their association with multimorbidity and demographic factors: a community-based, cross-sectional survey in Karachi, Pakistan.
    Farooq S; Khan T; Zaheer S; Shafique K
    BMJ Open; 2019 Nov; 9(11):e029315. PubMed ID: 31748286
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Associations between multimorbidity and glycaemia (HbA1c) in people with type 2 diabetes: cross-sectional study in Australian general practice.
    Chiang JI; Furler J; Mair F; Jani BD; Nicholl BI; Thuraisingam S; Manski-Nankervis JA
    BMJ Open; 2020 Nov; 10(11):e039625. PubMed ID: 33243798
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevalence, factors and inequalities in chronic disease multimorbidity among older adults in India: analysis of cross-sectional data from the nationally representative Longitudinal Aging Study in India (LASI).
    Chauhan S; Patel R; Kumar S
    BMJ Open; 2022 Mar; 12(3):e053953. PubMed ID: 35351706
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of COVID-19 Pandemic on Patients with Non-Communicable Disease: An Observational Cross-Sectional Study at AYUSH Set-Ups of Krishna and Darjeeling District, India.
    Varanasi R; Nayak D; Kumar A; Choubey G; Chinta R; Oberai P; Khurana A
    Complement Med Res; 2023; 30(2):95-106. PubMed ID: 35016186
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevalence and factors associated with multimorbidity among older adults in Malaysia: a population-based cross-sectional study.
    Shariff Ghazali S; Seman Z; Zainuddin NH; Omar MA; Sooryanarayana R; Ariaratnam S; Mohd Tohit N; Ho BK; Krishnapillai AD; Zainal Abidin SI
    BMJ Open; 2021 Oct; 11(10):e052126. PubMed ID: 34670764
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevalence of Multimorbidity of Chronic Noncommunicable Diseases in Brazil: Population-Based Study.
    Shi X; Lima SMDS; Mota CMM; Lu Y; Stafford RS; Pereira CV
    JMIR Public Health Surveill; 2021 Nov; 7(11):e29693. PubMed ID: 34842558
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevalence and Determinants of Multimorbidity, Polypharmacy, and Potentially Inappropriate Medication Use in the Older Outpatients: Findings from EuroAgeism H2020 ESR7 Project in Ethiopia.
    Bhagavathula AS; Seid MA; Adane A; Gebreyohannes EA; Brkic J; Fialová D
    Pharmaceuticals (Basel); 2021 Aug; 14(9):. PubMed ID: 34577544
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Medication Adherence Among Patients with Multimorbidity in the United Arab Emirates.
    Allaham KK; Feyasa MB; Govender RD; Musa AMA; AlKaabi AJ; ElBarazi I; AlSheryani SD; Al Falasi RJ; Khan MAB
    Patient Prefer Adherence; 2022; 16():1187-1200. PubMed ID: 35572810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.